Dare you use medicines sacrificed?

Dare you use medicines sacrificed?
March 20 of www.people.com.cn Beijing (reporter Fu LiBo) According to the result of calling for bid of base medicine that Shandong announces, the biding price of 250ml vial infusion is only 0.87 yuan bottle. Through calculate, at least in 1.10 bottle social average production cost of product this. "Enterprise's development needs profits to support, and is lower than cost price to sell, among them the hidden trick is thought-provoking. This kind of medicines, dare you use? "
To this phenomenon, when the deputy to the National People's Congress has wealth to accept www.people.com.cn's reporter's special visit in week, show the great worry. He says " at present, the base medicine that every province makes has greater differences to bid and purchase the principle, win a bid of result, implementation and quality having priority, guideline with reasonable price actually. "
The biding price of some products is lower than the average production cost of the trade, this equates with chronically to commit suicide. Dump behavior while being improper while being such, lead to the fact basic the intersection of medicine and product quality and supply and ensure having enormous risks on one hand; On the other hand push the medical industry of nationality of our country to the condition of withering away. Because the price was influenced, products and national medicine of country at present have already had more than 600 kinds to quit listing.
So as, contrast, imported medicine, joint-venture medicine enjoy ultra national treatment. Imported medicines are enjoyed within patent protection period to price alone, excessively high, some even cross the intersection of patent and variety of issue, too can enjoy " the single the intersection of level and price competition " in not calling for bid Exceed national treatment.
The medicines that the joint venture produces compare with domestic medicine, the efficiency is basically the same, but several times higher even more than ten times of price. Taking spore's Qusong of very beginning as examples, " Luo is fragrant " for the products of Roche Group ,The end of 2010 from 97 yuans /drop by 65 yuans to only /only,but 1.2 yuans medicines domestic /only. According to statistics, the imported medicine, clinical proportion in the large-scale hospital of our country of joint-venture medicine take more than 70% of the share.
At present, the basic medicine system walks with difficulty in the course of implementing and carrying out, face a great deal of difficulties and pressures. I propose, accelerate setting up medicines to call for bid in the pricing mechanism, relieve the basic medicine system to " it is difficult to implement " effectively , " it is difficult to carry out " Question.
There is wealth and introduce, this mechanism includes four respects in week. First of all, insist " quality has priority, the price is reasonable " Principle. This principle has been considered product quality is the principal aspect of a contradiction, and a kind of rational bidding design. So, the country lays particular emphasis on while making the policy to some extent. Namely: The quality of medicines is concerning the major issue of ordinary people's vital interests, it is the first's. Proposing every province should follow this basic principle strictly while making the rule of calling for bid of medicines.
Secondly, make improving, science, rational medicines quality evaluation system. Set up and set up national-levelly and evaluate the organization, set up the quantized subject standard to the quality of medicines. Grade to bid enterprises synthetically according to key elements such as quality of the basic medicine and price,etc. while making the rule of calling for bid of medicines, abandon " the having of the bottom price " Simple practice.
Third, improve medicines and call for bid in the definite mechanism of the tender price. Medicines are not the ordinary goods, the price of medicines should not only reflect economic worth, should reflect its clinical value even more. The medicines pricing mechanism should consider factors such as production cost, quality system, market share, clinical curative effect, and the guarantee levels and innovation ability of enterprises,etc. synthetically. Among them, production cost, quality system and innovation ability should take the main weight. Major enterprises can control the cost and ensure the quality of products effectively through the large-scale production, the market share of the products is high, research and develop and innovate to have high input, the brand effect is good, propose for rational support in calling for bid.
Fourth, encourage innovations, foster nationality's medical industry. The medical enterprises of the nationality should be since low-level breaking out when compete with quality, it is essential to promote and research and develop innovation ability. Propose for more support on policy of the autonomous innovation products of medical enterprises of nationality in medicines call for bid, Japan consumes medicines at under 3 yuan and is based on government issused price, it is unsuitable to participate in the price competition of calling for bid.
|